Correlation Between Denali Therapeutics and Regenxbio
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Regenxbio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Regenxbio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Regenxbio, you can compare the effects of market volatilities on Denali Therapeutics and Regenxbio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Regenxbio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Regenxbio.
Diversification Opportunities for Denali Therapeutics and Regenxbio
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Denali and Regenxbio is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Regenxbio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenxbio and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Regenxbio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenxbio has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Regenxbio go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Regenxbio
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 0.97 times more return on investment than Regenxbio. However, Denali Therapeutics is 1.03 times less risky than Regenxbio. It trades about 0.05 of its potential returns per unit of risk. Regenxbio is currently generating about -0.04 per unit of risk. If you would invest 1,837 in Denali Therapeutics on September 3, 2024 and sell it today you would earn a total of 726.00 from holding Denali Therapeutics or generate 39.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Regenxbio
Performance |
| Timeline |
| Denali Therapeutics |
| Regenxbio |
Denali Therapeutics and Regenxbio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Regenxbio
The main advantage of trading using opposite Denali Therapeutics and Regenxbio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Regenxbio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenxbio will offset losses from the drop in Regenxbio's long position.| Denali Therapeutics vs. DiaMedica Therapeutics | Denali Therapeutics vs. Lyra Therapeutics | Denali Therapeutics vs. Centessa Pharmaceuticals PLC |
| Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |